Donald Trump speaks to Indian Prime Minister and suggests Retaliation if Drugs not Dispatched

AFTER first appearing not to take the threat of coronavirus Covid-19 seriously, US President Donald Trump has now decided that the anti-malarial drug hydroxychloroquine has the potential to become “one of the biggest game changers in the history of medicine.”

This opinion is based on the fact that it appears to have had some success in calming down an overactive immune system which may make a difference for those suffering from the virus, but the studies in China and France are only in early stages.

As coronavirus has escalated in the USA, President Trump has been promoting the drug as a possible antidote encouraging people to use it by saying “What have you got to lose?”

According to the President of the American Medical Association, the potential side effects which include loss of vision and heart problems could see people losing their lives.

Undaunted, the President telephoned the Prime Minister of India Narendra Modi after learning that the Indian government planned to prohibit the exportation of the drug and asked that America’s orders be respected.

He later said in a White House press statement “I said we’d appreciate you allowing our supply to come out. If he doesn’t allow it to come out, that would be okay, but of course there may be retaliation. Why wouldn’t there be?”

Within days the Indian government reverses its decision to ban the export of the drug.

Written by

John Smith

Married to Ophelia in Gibraltar in 1978, John has spent much of his life travelling on security print and minting business and visited every continent except Antarctica. Having retired several years ago, the couple moved to their house in Estepona and John became a regular news writer for the EWN Media Group taking particular interest in Finance, Gibraltar and Costa del Sol Social Scene. Currently he is acting as Editorial Consultant for the paper helping to shape its future development. Share your story with us by emailing newsdesk@euroweeklynews.com, by calling +34 951 38 61 61 or by messaging our Facebook page www.facebook.com/EuroWeeklyNews

Comments